These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 16707436)
1. The phosphoinositide 3-kinase/Akt pathway: a new target in human renal cell carcinoma therapy. Sourbier C; Lindner V; Lang H; Agouni A; Schordan E; Danilin S; Rothhut S; Jacqmin D; Helwig JJ; Massfelder T Cancer Res; 2006 May; 66(10):5130-42. PubMed ID: 16707436 [TBL] [Abstract][Full Text] [Related]
2. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer. Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells. Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766 [TBL] [Abstract][Full Text] [Related]
4. The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway. Bussolati B; Assenzio B; Deregibus MC; Camussi G J Mol Med (Berl); 2006 Oct; 84(10):852-63. PubMed ID: 16924472 [TBL] [Abstract][Full Text] [Related]
5. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition. Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. Kunnimalaiyaan M; Ndiaye M; Chen H Surgery; 2006 Dec; 140(6):1009-14; discussion 1014-5. PubMed ID: 17188151 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of phosphatidylinositol 3-kinase/Akt and histone deacetylase activity induces apoptosis in non-small cell lung cancer in vitro and in vivo. Denlinger CE; Rundall BK; Jones DR J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1422-9. PubMed ID: 16256798 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo. Bondar VM; Sweeney-Gotsch B; Andreeff M; Mills GB; McConkey DJ Mol Cancer Ther; 2002 Oct; 1(12):989-97. PubMed ID: 12481421 [TBL] [Abstract][Full Text] [Related]
9. LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-Akt pathway. Poh TW; Pervaiz S Cancer Res; 2005 Jul; 65(14):6264-74. PubMed ID: 16024628 [TBL] [Abstract][Full Text] [Related]
10. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism. Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636 [TBL] [Abstract][Full Text] [Related]
11. Role of mimic of manganese superoxide dismutase in proliferation and apoptosis of gastric carcinoma BGC-823 cells in vitro and in vivo. Wang YH; Zhou ZB; Guo CA; Zhai J; Qi FM; Li HL Int Immunopharmacol; 2015 Jun; 26(2):277-85. PubMed ID: 25889634 [TBL] [Abstract][Full Text] [Related]
12. Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin. Liu D; Hou P; Liu Z; Wu G; Xing M Cancer Res; 2009 Sep; 69(18):7311-9. PubMed ID: 19706758 [TBL] [Abstract][Full Text] [Related]
13. Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells. Li B; Cheung PY; Wang X; Tsao SW; Ling MT; Wong YC; Cheung AL Carcinogenesis; 2007 Nov; 28(11):2313-20. PubMed ID: 17638919 [TBL] [Abstract][Full Text] [Related]
14. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921 [TBL] [Abstract][Full Text] [Related]
15. Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy. Sourbier C; Danilin S; Lindner V; Steger J; Rothhut S; Meyer N; Jacqmin D; Helwig JJ; Lang H; Massfelder T Cancer Res; 2007 Dec; 67(24):11668-76. PubMed ID: 18089796 [TBL] [Abstract][Full Text] [Related]
16. Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway. Nan Y; Guo L; Song Y; Wang L; Yu K; Huang Q; Zhong Y J Cancer Res Clin Oncol; 2017 Aug; 143(8):1477-1487. PubMed ID: 28401302 [TBL] [Abstract][Full Text] [Related]
17. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway. Nguyen DM; Chen GA; Reddy R; Tsai W; Schrump WD; Cole G; Schrump DS J Thorac Cardiovasc Surg; 2004 Feb; 127(2):365-75. PubMed ID: 14762343 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of LY294002 and wortmannin on inducible nitric oxide synthase expression in glomerular mesangial cells. Tsai KD; Chang WW; Lin CC; Hsu SC; Lee YJ; Chen W; Shieh JC; Lin TH Int Immunopharmacol; 2012 Mar; 12(3):471-80. PubMed ID: 22240122 [TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells. Pitt SC; Chen H; Kunnimalaiyaan M J Am Coll Surg; 2009 Jul; 209(1):82-8. PubMed ID: 19651067 [TBL] [Abstract][Full Text] [Related]
20. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process. Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]